The Cancer Researcher
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious
No Result
View All Result
The Cancer Researcher
No Result
View All Result

Highlights in Cancer Research: March 2025

October 17, 2025
Highlights in Cancer Research: November 2022

Related articles

VIDEO | How to get through “failure” in a research career

Scientific Highlights from Cancer Researchers to Watch: An Early Career Showcase

The EACR’s ‘Highlights in Cancer Research’ is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of the European Association for Cancer Research (EACR).

The list below appears in no particular order, and the summary information has been provided by the authors unless otherwise indicated.

Use the dropdown menu or ‘Previous’ and ‘Next’ buttons to navigate the list.


6. Survivin Promotes Stem Cell Competence for Skin Cancer Initiation

  • 1. Immune evasion through mitochondrial transfer in the tumour microenvironment
  • 2. Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma
  • 3. Controlling intracellular protein delivery, tumor colonization and tissue distribution using flhDC in clinically relevant ΔsseJ Salmonella
  • 4. Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer
  • 5. Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
  • 6. Survivin Promotes Stem Cell Competence for Skin Cancer Initiation
  • 7. Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancer
  • 8. Development of patient-derived lymphomoids with preserved tumor architecture for lymphoma therapy screening
  • 9. Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment
  • 10. Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease
Previous
Next

Canato, S. et al. Cancer Discovery. 15(2): 427–443. (2025).
doi: 10.1158/2159-8290.CD-24-0263.

Summary of the findings

Basal cell carcinoma (BCC) is the most frequent cancer in humans. Stem cells (SCs) but not progenitors are competent to initiate BCC formation following oncogenic hedgehog signaling activation. However, the mechanisms conferring the competence to BCC formation in SCs and restricting tumour formation in progenitors were not known. This study uncovered the mechanisms allowing SCs and not progenitors to initiate BCC formation.
.
Canato and colleagues uncovered that Survivin, a protein regulating proliferation and apoptosis, is expressed at a higher level in SCs compared to progenitors. Using genetic gain and loss of function of Survivin in mouse models, the authors showed that Survivin deletion in oncogene-expressing SCs prevents BCC formation, whereas Survivin overexpression renders oncogene-expressing progenitors competent to BCC formation. Survivin expression enhances cell survival and renewing divisions, while restricting apoptosis and differentiation. The authors showed that pharmacological inhibition of Survivin or of SGK1, a downstream factor regulated by Survivin, prevents the conversion of preneoplastic lesions into invasive BCCs.
.

Altogether, this study identifies Survivin as a key licensing factor expressed by SCs that regulate BCC formation by promoting self-renewal and survival, while preventing cell death and differentiation in oncogene-expressing cells. In addition, the demonstration that Survivin expression is required for BCC formation suggests that Survivin or SGK1 inhibitors can be used to prevent the progression of preneoplastic lesions into invasive skin cancer.

.
Read more in Cancer Discovery

6. Survivin Promotes Stem Cell Competence for Skin Cancer Initiation

  • 1. Immune evasion through mitochondrial transfer in the tumour microenvironment
  • 2. Concurrent SOS1 and MEK suppression inhibits signaling and growth of NF1-null melanoma
  • 3. Controlling intracellular protein delivery, tumor colonization and tissue distribution using flhDC in clinically relevant ΔsseJ Salmonella
  • 4. Chemotherapy induces myeloid-driven spatially confined T cell exhaustion in ovarian cancer
  • 5. Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma
  • 6. Survivin Promotes Stem Cell Competence for Skin Cancer Initiation
  • 7. Multiparameter imaging reveals clinically relevant cancer cell-stroma interaction dynamics in head and neck cancer
  • 8. Development of patient-derived lymphomoids with preserved tumor architecture for lymphoma therapy screening
  • 9. Blocking IL1RAP on cancer-associated fibroblasts in pancreatic ductal adenocarcinoma suppresses IL-1-induced neutrophil recruitment
  • 10. Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease
Previous
Next
Tags: EACR Top Ten Cancer Research PublicationsHighlights in Cancer Research

Related Posts

VIDEO |  How to get through “failure” in a research career

VIDEO | How to get through “failure” in a research career

October 16, 2025

Click above to watch At the Early Career Researchers’ Conference 2025, we enjoyed a brilliant programme of diverse sessions from a range of experts, including Joan...

Scientific Highlights from Cancer Researchers to Watch: An Early Career Showcase

Scientific Highlights from Cancer Researchers to Watch: An Early Career Showcase

July 16, 2025

Dr. Alexandra Boitor, EACR Scientific Officer, gives a few of the highlights from Cancer Researchers to Watch: An early career showcase (Lisbon, 15-16 June 2025). The EACR's...

Highlights in Cancer Research: November 2022

Highlights in Cancer Research: July 2025

October 17, 2025

The EACR's 'Highlights in Cancer Research' is a regular summary of the most interesting and impactful recent papers in cancer research, curated by the Board of...

The Cancer Researcher EACR logo

About Us

The Cancer Researcher is an online magazine for the cancer research community from the European Association for Cancer Research.

The EACR, a registered charity, is a global community for those working and studying in cancer research. Our mission is “The advancement of cancer research for the public benefit: from basic research to prevention, treatment and care.”

RECENT POSTS

Behind the scenes at the EACR Congress – Episode 26 of The Cancer Researcher Podcast
Podcast

Behind the scenes at the EACR Congress – Episode 26 of The Cancer Researcher Podcast

November 7, 2025
“A combination of professional growth and personal discovery”: Ana Baião’s EACR Travel Fellowship
Community

“A combination of professional growth and personal discovery”: Ana Baião’s EACR Travel Fellowship

November 5, 2025
The Cancer Researcher

© 2025 EACR

Navigate site

  • About
  • Privacy
  • Main EACR website

Follow us

Table of Contents

×
  • Related articles
  • VIDEO | How to get through “failure” in a research career
  • Scientific Highlights from Cancer Researchers to Watch: An Early Career Showcase
  • 6. Survivin Promotes Stem Cell Competence for Skin Cancer Initiation
    • Summary of the findings
    • Altogether, this study identifies Survivin as a key licensing factor expressed by SCs that regulate BCC formation by promoting self-renewal and survival, while preventing cell death and differentiation in oncogene-expressing cells. In addition, the demonstration that Survivin expression is required for BCC formation suggests that Survivin or SGK1 inhibitors can be used to prevent the progression of preneoplastic lesions into invasive skin cancer.
  • 6. Survivin Promotes Stem Cell Competence for Skin Cancer Initiation
→ Table of Contents
No Result
View All Result
  • Home
  • About
  • The Cancer Researcher Podcast
  • #KeepResearchCurious

© 2025 EACR